Alpha Cognition (ACOG) Net Income towards Common Stockholders (2023 - 2025)

Alpha Cognition's (ACOG) quarterly Net Income towards Common Stockholders came in at -$6.9 million in Q4 2025, down 18.0% year-on-year from -$8.4 million in Q4 2024, and down 420.18% quarter-over-quarter from -$1.3 million in Q3 2025.

Alpha Cognition (ACOG) Net Income towards Common Stockholders (2023 - 2025) Analysis & Trends

Alpha Cognition's Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$6.9 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 18.0% year-over-year to -$6.9 million in Q4 2025; TTM through Dec 2025 was -$20.7 million, a 39.77% decrease from a year earlier, with the FY2025 full-year figure at -$20.7 million, down 39.77% from the prior year.
  • Net Income towards Common Stockholders fell to -$6.9 million in Q4 2025 per ACOG's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$1.3 million in Q3 2025 and bottomed at -$10.5 million in Q2 2025.
  • The 3-year median for Net Income towards Common Stockholders is -$3.3 million (2023), against an average of -$4.3 million.
  • Biggest YoY gain for Net Income towards Common Stockholders was 59.89% in 2025; the steepest drop was 395.81% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$5.7 million in 2023, then slipped by 1.68% to -$5.8 million in 2024, then fell by 18.0% to -$6.9 million in 2025.
  • Per Business Quant, the three latest ACOG Net Income towards Common Stockholders figures stand at -$6.9 million (Q4 2025), -$1.3 million (Q3 2025), and -$10.5 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -625.73
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -0.68
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 472.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -453.82 Mn
10 Alpha Cognition 146.84 Mn 80.73 Mn 2.61 Mn -6.86 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.86 Mn
Sep 30, 2025 -1.32 Mn
Jun 30, 2025 -10.49 Mn
Mar 31, 2025 -2.01 Mn
Dec 31, 2024 -5.81 Mn
Sep 30, 2024 -1.86 Mn
Jun 30, 2024 -2.12 Mn
Mar 31, 2024 -5.00 Mn
Dec 31, 2023 -5.71 Mn
Sep 30, 2023 -3.27 Mn
Jun 30, 2023 -2.73 Mn